Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 4 chart positions in 4 markets.
By chart position
- 🇲🇾MY · Science#2310K to 30K
- 🇭🇰HK · Science#2510K to 30K
- 🇰🇪KE · Science#109500 to 3K
- 🇹🇼TW · Science#178500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
11K to 33K🎙 ~2x weekly·196 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
21K to 66K🇲🇾45%🇭🇰45%🇰🇪5%+1 more - Active Followers
Loyal subscribers who consistently listen
6.3K to 20K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 15 epsHost
Recent guests
Recent episodes
Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With
Jul 14, 2026
1h 08m 18s
Ep204: Troy Wilson on Precision Cancer Drugs and Combos
Jun 30, 2026
1h 07m 27s
Ep203: Sri Kosuri on Small Molecule Correctors of Disease
Jun 16, 2026
1h 11m 43s
Ep202: Becky Pferdehirt on Reimagining Science for the AI Era
Jun 2, 2026
1h 08m 12s
Ep201: Jeremy Levin on Biotech in the Balance
May 19, 2026
1h 08m 40s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/14/26 | schizophreniadrug development+3 | Heather Turner | schizophrenia drugLB Pharma | New York | schizophreniadrug+5 | — | 1h 08m 18s | ||
| 6/30/26 | precision medicinecancer drugs+3 | Troy Wilson | Kura Oncology | San Diego | precision cancer drugsbiotech career+3 | — | 1h 07m 27s | ||
| 6/16/26 | small moleculesprotein misfolding+3 | Sri Kosuri | Octant Bio | Emeryville, Calif. | small moleculesprotein misfolding+3 | — | 1h 11m 43s | ||
| 6/2/26 | AI in biologylife sciences+3 | Becky Pferdehirt | RadialAstera Institute | Emeryville, CA | AIbiology+3 | — | 1h 08m 12s | ||
| 5/19/26 | biotechindustry trust+3 | Jeremy Levin | Ovid TherapeuticsBiotech in the Balance | — | biotechOvid Therapeutics+5 | — | 1h 08m 40s | ||
| 5/5/26 | sleep disordersorexin drugs+3 | Richard Pops | AlkermesThe Long Run with Luke Timmerman | — | Orexinsleep disorders+5 | — | 1h 13m 31s | ||
| 4/21/26 | small molecule medicinesAI in chemistry+3 | Marty Burke | University of IllinoisExcelsior Sciences | — | small moleculesAI+3 | — | 1h 10m 08s | ||
| 4/7/26 | drug discoverycomputation+3 | Abbas Kazimi | Nimbus Therapeutics | Boston | drug discoverycomputation+3 | — | 1h 16m 43s | ||
| 3/31/26 | drug discoverynatural products+3 | Viswa Colluru | Enveda | Boulder, Colo. | drug discoverynatural products+3 | — | 1h 16m 57s | ||
| 3/17/26 | biotech investmentEurope+3 | Otello Stampacchia | Omega Funds | Europebiotech | biotechinvestment+5 | — | 1h 03m 17s | ||
| 3/3/26 | T-cell engagersautoimmune diseases+3 | Ken Song | Candid Therapeutics | San Diego | T-cell engagersautoimmune diseases+3 | — | 1h 05m 45s | ||
| 2/17/26 | CancerAutoimmune Drug Discovery+3 | Ansu Satpathy | Timmerman Report | — | cancerautoimmune+3 | — | 1h 08m 54s | ||
| 1/22/26 | GLP-1 medicinesweight loss+3 | Ron Renaud | Kailera Therapeutics | Waltham, Mass. | GLP-1weight loss+3 | — | 1h 05m 10s | ||
| 1/8/26 | precision immunologybiotechnology+3 | Kate Haviland | Blueprint MedicinesSanofi | — | Kate HavilandBlueprint Medicines+5 | — | 1h 26m 06s | ||
| 12/15/25 | kidney diseasebiotechnology+3 | Emily Conley | Renasant Bioautosomal dominant polycystic kidney disease (ADPKD) | Berkeley, CA | ADPKDsmall molecule correctors+3 | — | 1h 07m 34s |
Showing 15 of 15
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for The Long Run with Luke Timmerman
Peaked at #23 in MY, currently #23 in MY.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| MY | — | #23 | #23 | — |
| HK | — | #25 | #25 | — |
| KE | — | #109 | #109 | — |
| TW | — | #178 | #178 | — |
Chart Positions
4 placements across 4 markets.
Chart Positions
4 placements across 4 markets.